GRADEMI BIOTECH SRL

Grademi Biotech is developing a patented device, X10 Pathology to enhance the diagnostic value of ESR testing. The erythrocyte sedimentation rate (ESR) is a widely used non-specific blood test for inflammation, used to help support the diagnosis of a wide range of diseases and monitor therapy. X10 Pathology correlates ESR rate in plasma to specific disease states creating new functionality and dramatically improved performance. This allows: more rapid and specific disease diagnosis; reduced need for additional diagnostic testing and improve disease monitoring. The X10 Pathology is undergoing validation testing at a leading hospital in Italy.